Eventide Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
|
|||||
2022
Q2 | $165M | Sell |
|
|||||
2022
Q1 | $194M | Hold |
|
|||||
2021
Q4 | $225M | Buy |
|
|||||
2021
Q3 | $184M | Sell |
|
|||||
2021
Q2 | $193M | Sell |
|
|||||
2021
Q1 | $138M | Buy |
|
|||||
2020
Q4 | $153M | Hold |
|
|||||
2020
Q3 | $116M | Hold |
|
|||||
2020
Q2 | $130M | Hold |
|
|||||
2020
Q1 | $60.7M | Buy |
|
|||||
2019
Q4 | $89M | Hold |
|
|||||
2019
Q3 | $68.2M | Buy |
|
|||||
2019
Q2 | $36M | Buy |
|
|||||
2019
Q1 | $25.4M | Hold |
|
|||||
2018
Q4 | $18.2M | Buy |
|
|||||
2018
Q3 | $11M | Buy |
|
|||||
2018
Q2 | $10M | Sell |
|
|||||
2018
Q1 | $8.91M | Buy |
|
|||||
2017
Q4 | $6.53M | Buy |
|
|||||
2017
Q3 | $1.99M | Hold |
|
|||||
2017
Q2 | $1.33M | Buy |
|